SPUR: psychometric properties of a patient-reported outcome measure of medication adherence in type 2 diabetes.
Joshua Sterling WellsAya El HusseiniSandra OkohAli JaffarClaire NeelyPhilip CrillyKevin DolginReem KayyaliPublished in: BMJ open (2022)
SPUR-27 demonstrated strong psychometric properties. Further work should look to examine the test-retest reliability of the model as well as examine transferability to other chronic conditions and broader population samples. Overall, the initial findings suggest that SPUR-27 is a reliable model for the multifactorial assessment of medication adherence among patients living with type 2 diabetes.